AI-assisted Rare Disease Diagnosis | MicrobiomeTrials← Back to trialsNCT07650799
AI-assisted Rare Disease Diagnosis
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-08-01Est. Completion: 2027-07-01
Enrollment target: 1,056 participants Locations- Peking Union Medical College Hospital, Beijing, China
- Cangzhou Central Hospital, Cangzhou, China
- Changchun Sacred Heart Hospital, Changchun, China
- Dongguan People's Hospital, Dongguan, China
- First People's Hospital of Foshan, Foshan, China
- Guizhou Provincial People's Hospital, Guiyang, China
- Jilin Central General Hospital, Jilin City, China
- The First People's Hospital of Yunnan Province, Kunming, China
- Tianjin Children's Hospital, Tianjin, China
- Tianshui 407 Hospital, Tianshui, China
- Wuhai People's Hospital, Wuhai, China
- Qinghai Provincial People's Hospital, Xining, China
- Zhangzhou Municipal Hospital of Fujian Province, Zhangzhou, China
ContactShuyang Zhang, MD, PhD
Other microbiome trials you might be interested in
Very Rare TumorsVery Rare CancersOther Solid TumorsSolid TumorPediatric Rare Tumors
Background:
All childhood cancers are rare, but some are called very rare. Very rare cancers are diagnosed in 2 or fewe…
Bethesda, United StatesEst. completion Apr 1, 2035
Obsessive - Compulsive DisorderTic Disorder, Chronic Motor or VocalTic DisordersTic Disorder, Combined Vocal and Multiple MotorTourette Disease
Tourette Disorder
Tourettes Syndrome
Gilles de la Tourette Syndrome
Obsessive-Compulsive Disorder and Tic Disorders frequently co-occur, and a subgroup of patients - those with a Tourettic…
London, United KingdomEst. completion Aug 1, 2027